ExploreWatchlistsPricing
  1. JP-listed companies
  2. TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
  3. Financials
  4. Net income

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. (E25678)

Market cap
P/E ratio
Taisho Pharmaceutical Holdings develops and sells both over-the-counter and prescription medicines, along with health products, serving customers in Japan and internationally.
SummaryFinancialsDividendsHistoryWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202321,302+42.49%
Mar 31, 202214,950-1.61%
Mar 31, 202115,194-30.58%
Mar 31, 202021,887-56.07%
Mar 31, 201949,825+49.32%
Mar 31, 201833,368+10.47%
Mar 31, 201730,205+26.48%
Mar 31, 201623,882-2.63%
Mar 31, 201524,528-24.97%
Mar 31, 201432,692+24.21%
Mar 31, 201326,320+8.06%
Mar 31, 201224,357

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat